Bank of America Securities Sticks to Its Buy Rating for McKesson (MCK)
In a report released today, Allen Lutz from Bank of America Securities reiterated a Buy rating on McKesson, with a price target of $1,040.00.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Lutz covers the Healthcare sector, focusing on stocks such as Hims & Hers Health, Doximity, and Teladoc. According to TipRanks, Lutz has an average return of 13.7% and a 65.43% success rate on recommended stocks.
Currently, the analyst consensus on McKesson is a Strong Buy with an average price target of $997.10.
Based on McKesson’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $106.16 billion and a net profit of $1.19 billion. In comparison, last year the company earned a revenue of $95.29 billion and had a net profit of $879 million
Based on the recent corporate insider activity of 50 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of MCK in relation to earlier this year. Last month, Maria Martinez, a Director at MCK sold 349.00 shares for a total of $328,011.14.
Read More on MCK:
Disclaimer & DisclosureReport an Issue
- McKesson CFO Britt Vitalone to retire, Kenny Cheung to succeed
- The Week That Was, The Week Ahead: Macro and Markets, Mar. 1
- McKesson price target raised to $1,050 from $960 at Barclays
- McKesson price target raised to $1,107 from $983 at JPMorgan
- McKesson Earnings Call Highlights Specialty and Tech Strength
